Perturbation of the P-Body Component Mov10 Inhibits HIV-1 Infectivity

• Vyacheslav Furtak,

  Affiliation Department of Microbiology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Alok Mulky,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Stephen A. Rawlings,

  Affiliation Department of Microbiology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• Lina Kozhaya,

  Affiliation Department of Microbiology, New York University School of Medicine, New York, New York, United States of America

  ⨯
• KyeongEun Lee,

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Vineet N. KewalRamani ,

  * E-mail: vineet@mac.com (VK); derya@mac.com (DU)

  Affiliation HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Derya Unutmaz

  * E-mail: vineet@mac.com (VK); derya@mac.com (DU)

  Affiliations Department of Microbiology, New York University School of Medicine, New York, New York, United States of America, Department of Pathology, New York University School of Medicine, New York, New York, United States of America

  ⨯